Study on the Effects of Cardiometabolic Conditions on Coronary Artery Disease and Cardiovascular Health

What this Trial Is About

The trial investigates the relationship between cardiometabolic factors and coronary artery diseases in patients with metabolic abnormalities such as diabetes, prediabetes, obesity, chronic kidney disease, and hyperuricemia. It is a prospective cohort study conducted at a single center, focusing on how these factors impact coronary disease progression and cardiovascular health over time. Participants with established coronary artery disease or metabolic disorders are enrolled and observed to assess changes in their coronary plaque and lesion severity over 12 months. Researchers also monitor cardiovascular events for up to five years to understand long-term outcomes linked to these metabolic conditions. During the study, participants undergo evaluations to measure coronary plaque progression and lesion severity, along with assessments of plaque characteristics. The study includes follow-up visits and monitoring to track cardiovascular events and disease progression. Participation spans from initial enrollment through at least one year for primary measurements and up to five years for secondary outcomes, providing a detailed understanding of disease development and risk factors.

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion